fluorometholone and Breast Cancer

fluorometholone has been researched along with Breast Cancer in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19906 (75.00)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawara, H; Mitani, T; Noguchi, Y; Shimizu, Y; Tamura, Y; Tokuyama, Y; Uchiyama, K1
GOOD, JD; HICKEY, RC; TIDRICK, RT1
DEDERICK, MM; HALL, TC; LOJANANOND, P; TAFT, PD1
MASS, RE1
DEDERICK, M; HALL, TC; NEVINNY, HB1
Berry, JP; Chassoux, D; Escaig, F; Galle, P; Lespinats, G; Linarez-Cruz, LG1
Finney, GG; Gaertner, RA; Lewison, EF; Montague, AC1
Goldenberg, IS1

Trials

2 trial(s) available for fluorometholone and Breast Cancer

ArticleYear
Combined hormone therapy in advanced breast cancer. Triple-blind study of 68 patients treated with dromostanolone and fluorometholone.
    The Johns Hopkins medical journal, 1968, Volume: 123, Issue:3

    Topics: Aged; Androstanols; Breast Neoplasms; Clinical Trials as Topic; Drug Synergism; Female; Fluorometholone; Humans; Middle Aged; Neoplasm Metastasis; Placebos

1968
Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group.
    Cancer, 1969, Volume: 23, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorometholone; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prognosis; Testolactone

1969

Other Studies

6 other study(ies) available for fluorometholone and Breast Cancer

ArticleYear
[A case of lacrimal duct obstruction caused by capecitabine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorometholone; Fluoroquinolones; Fluorouracil; Gatifloxacin; Hand-Foot Syndrome; Humans; Lacrimal Duct Obstruction

2015
OXYLONE (NSC-33001) AS A PALLIATIVE AGENT IN ADVANCED MAMMARY CANCER.
    Cancer chemotherapy reports, 1963, Volume: 31

    Topics: Breast; Breast Neoplasms; Fluorometholone; Humans; Neoplasms

1963
EFFECT OF THERAPY UPON VAGINAL SMEARS IN BREAST CANCER PATIENTS.
    Surgery, gynecology & obstetrics, 1964, Volume: 118

    Topics: Animals; Biomedical Research; Breast Neoplasms; Diethylstilbestrol; Ethinyl Estradiol; Female; Fluorometholone; Gonadotropins; Gonadotropins, Equine; Horses; Humans; Methotrexate; Methyltestosterone; Pharmacology; Prednisone; Testosterone; Vaginal Smears

1964
CLINICAL EVALUATION OF OXYLONE (NSC-33001).
    Cancer chemotherapy reports, 1964, Volume: 38

    Topics: Biomedical Research; Breast Neoplasms; Carcinoma, Bronchogenic; Cushing Syndrome; Duodenal Ulcer; Fluorometholone; Gastrointestinal Neoplasms; Geriatrics; Hemorrhage; Humans; Hyperglycemia; Intestinal Perforation; Leukocytosis; Melanoma; Peptic Ulcer; Pharmacology; Stomach Ulcer; Toxicology; Urogenital Neoplasms

1964
OXYLONE ACETATE (NSC-47438) IN HORMONE-RESISTANT BREAST CANCER IN HUMANS.
    Cancer chemotherapy reports, 1964, Volume: 39

    Topics: Acetates; Breast; Breast Neoplasms; Fluorometholone; Humans; Hypercalcemia; Neoplasms

1964
Mapping of intracellular halogenous molecules by low and high resolution SIMS microscopy.
    Biology of the cell, 1992, Volume: 74, Issue:1

    Topics: Adrenal Cortex Hormones; Androgens; Breast Neoplasms; Bromocriptine; Bromodeoxyuridine; Cells, Cultured; Fluorometholone; Halogens; Humans; Mass Spectrometry; Microscopy; Mitosis; Nucleotides; Triamcinolone; Tumor Cells, Cultured

1992